Terms: = Endocrine gland cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Treatment
46 results:
1. The relationship between DNA mismatch repair gene and other prognostic parameters in pancreatic adenocarcinoma.
Urganci N; Kepil N; Ergun S; Bakkaloglu OK
J Surg Oncol; 2024 Apr; 129(5):876-884. PubMed ID: 38173349
[TBL] [Abstract] [Full Text] [Related]
2. Expression of EGFR, PD-L1, and the mismatch repair proteins before and following therapy in malignant serous effusions with metastatic high-grade serous tubo-ovarian carcinoma.
Nikas IP; Park SY; Song MJ; Lee C; Ryu HS
Diagn Cytopathol; 2024 Feb; 52(2):69-75. PubMed ID: 37937321
[TBL] [Abstract] [Full Text] [Related]
3. Deep Learning Can Predict Bevacizumab Therapeutic Effect and Microsatellite Instability Directly from Histology in Epithelial Ovarian cancer.
Wang CW; Lee YC; Lin YJ; Firdi NP; Muzakky H; Liu TC; Lai PJ; Wang CH; Wang YC; Yu MH; Wu CH; Chao TK
Lab Invest; 2023 Nov; 103(11):100247. PubMed ID: 37741509
[TBL] [Abstract] [Full Text] [Related]
4. Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas.
Medina EJ; Zohdy YM; Porto E; Revuelta Barbero JM; Bray D; Maldonado J; Rodas A; Mayol M; Morales B; Neill S; Read W; Pradilla G; Ioachimescu A; Garzon-Muvdi T
Front Endocrinol (Lausanne); 2023; 14():1195792. PubMed ID: 37529607
[TBL] [Abstract] [Full Text] [Related]
5. Ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract] [Full Text] [Related]
6. Germline drivers of gynecologic carcinosarcomas.
Sia TY; Gordhandas SB; Birsoy O; Kemel Y; Maio A; Salo-Mullen E; Sheehan M; Hensley ML; Rubinstein M; Makker V; Grisham RN; O'Cearbhaill RE; Roche KL; Mueller JJ; Leitao MM; Sonoda Y; Chi DS; Abu-Rustum NR; Berger MF; Ellenson LH; Latham A; Stadler Z; Offit K; Aghajanian C; Weigelt B; Mandelker D; Liu YL
Gynecol Oncol; 2023 Jul; 174():34-41. PubMed ID: 37149903
[TBL] [Abstract] [Full Text] [Related]
7. Endometrioid Endometrial Carcinoma With NKX3.1 Expression in a Transgender Man: A Case Report.
Yoshida H; Uno M; Ogimoto K; Kobayashi-Kato M; Tanase Y; Ishikawa M; Kato T
Int J Gynecol Pathol; 2023 May; 42(3):308-314. PubMed ID: 36811847
[TBL] [Abstract] [Full Text] [Related]
8. Maintenance therapy of low-dose nivolumab, S-1, and leucovorin in metastatic pancreatic adenocarcinoma with a germline mutation of
Peng SH; Chen BB; Kuo TC; Lee JC; Yang SH
Front Immunol; 2022; 13():1077840. PubMed ID: 36582237
[TBL] [Abstract] [Full Text] [Related]
9. Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis.
Sakamoto I; Hirotsu Y; Amemiya K; Nozaki T; Mochizuki H; Omata M
J Gynecol Oncol; 2023 Jan; 34(1):e6. PubMed ID: 36245225
[TBL] [Abstract] [Full Text] [Related]
10. The clinical features and management of Lynch syndrome-associated ovarian cancer.
Ran X; Jing H; Li Z
J Obstet Gynaecol Res; 2022 Jul; 48(7):1538-1545. PubMed ID: 35478369
[TBL] [Abstract] [Full Text] [Related]
11. Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma.
Qiao PP; Tian KS; Han LT; Ma B; Shen CK; Zhao RY; Zhang Y; Wei WJ; Chen XP
Endocrine; 2022 Jun; 76(3):660-670. PubMed ID: 35366156
[TBL] [Abstract] [Full Text] [Related]
12. Pancreatic cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
[TBL] [Abstract] [Full Text] [Related]
13. A correlation study of mismatch repair immunohistochemical protein expression of pancreatic solid tumors in cytology cell blocks and matching surgical specimens.
Teodosescu A; Chan I; Elder J; Wu M
Diagn Cytopathol; 2021 Jun; 49(6):700-705. PubMed ID: 33615705
[TBL] [Abstract] [Full Text] [Related]
14. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast cancer or Ovarian cancer, 2012-2019.
Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ
J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870
[TBL] [Abstract] [Full Text] [Related]
15. Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression.
Mei Y; Bi WL; Agolia J; Hu C; Giantini Larsen AM; Meredith DM; Al Abdulmohsen S; Bale T; Dunn GP; Abedalthagafi M; Dunn IF
Pituitary; 2021 Jun; 24(3):359-373. PubMed ID: 33492612
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study.
Majd N; Waguespack SG; Janku F; Fu S; Penas-Prado M; Xu M; Alshawa A; Kamiya-Matsuoka C; Raza SM; McCutcheon IE; Naing A
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33427689
[TBL] [Abstract] [Full Text] [Related]
17. Diffuse Intratumoral Stromal Inflammation in Ovarian Clear Cell Carcinoma is Associated With Loss of Mismatch Repair Protein and High PD-L1 Expression.
Lin SY; Hang JF; Lin YY; Lai CR; Ho HL; Chou TY
Int J Gynecol Pathol; 2021 Mar; 40(2):148-155. PubMed ID: 32897958
[TBL] [Abstract] [Full Text] [Related]
18. The utility of immunohistochemical testing for mismatch repair proteins in fine needle aspiration specimens of pancreatic adenocarcinoma.
Mettman D; Haer E; Olyaee M; Rastogi A; Madan R; O'Neil M; Kelting S; Dennis K; Fan F
Ann Diagn Pathol; 2020 Aug; 47():151552. PubMed ID: 32570025
[TBL] [Abstract] [Full Text] [Related]
19. Pancreatic ductal adenocarcinoma with mismatch repair deficiency resected after long-term observation.
Ogasawara N; Imamura T; Koyama R; Inoshita N; Nakayama A; Hattori D; Ito Y; Sato Y; Tamura T; Hashimoto M
Clin J Gastroenterol; 2020 Oct; 13(5):959-968. PubMed ID: 32424776
[TBL] [Abstract] [Full Text] [Related]
20. Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: study of 13 cases comparing ductal pancreatic carcinoma and review of the literature.
Hrudka J; Lawrie K; Waldauf P; Ciprová V; Moravcová J; Matěj R
Virchows Arch; 2020 Nov; 477(5):687-696. PubMed ID: 32424767
[TBL] [Abstract] [Full Text] [Related]
[Next]
